% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Stewart:170152,
author = {K. L. Stewart and B. Gigic and C. Himbert and C. A. Warby
and J. Ose and T. Lin and P. Schrotz-King$^*$ and J. Boehm
and K. C. Jordan and J. Metos and M. Schneider and J. C.
Figueiredo and C. I. Li and D. Shibata and E. Siegel and A.
T. Toriola and S. Hardikar and C. M. Ulrich},
title = {{A}ssociation of {S}ugar {I}ntake with {I}nflammation- and
{A}ngiogenesis-{R}elated {B}iomarkers in {N}ewly {D}iagnosed
{C}olorectal {C}ancer {P}atients.},
journal = {Nutrition and cancer},
volume = {74},
number = {5},
issn = {1532-7914},
address = {New York, NY},
publisher = {Routledge, Taylor $\&$ Francis Group},
reportid = {DKFZ-2021-01782},
pages = {1636-1643},
year = {2022},
note = {2022;74(5):1636-1643},
abstract = {Evidence suggests a positive association between sugar
intake and colorectal cancer (CRC) outcomes. We sought to
investigate inflammation and angiogenesis as underlying
mechanisms behind increased sugar intake and worse CRC
outcomes. Pre-surgery serum samples were obtained from 191
patients diagnosed with primary invasive stage I-IV CRC.
Biomarkers of inflammation (CRP, SAA, IL-6, IL-8, MCP-1,
TNFα) and angiogenesis (VEGFA, VEGFD, sICAM-1 and sVCAM-1)
were analyzed (Meso-Scale-Discovery). Fructose, glucose,
sucrose, and total sugar intake (calories/day, $\%$ total
calories) were assessed by FFQ. Pearson's correlation and
multiple linear regression analyses were performed. Patients
were on average 64 years old, $64\%$ were male, the majority
was diagnosed with stage II-III $(58\%)$ cancers, and $67\%$
were either overweight or obese. Among normal-weight
individuals (BMI <25 kg/m2), we observed a significant
inverse association between VEGFD and any type of sugar
intake in cal/day (sucrose: p = 0.01, glucose and fructose:
p < 0.001) and MCP-1 and fructose intake (p = 0.05). The
magnitude of reduction in VEGF ranged between -1.24 for
sucrose to 4.49 for glucose intake, and -2.64 for fructose
intake for MCP-1 levels. Sugar intake was associated with
some inflammation or angiogenesis biomarkers, among CRC
patients; differences were observed by adiposity that
warrant further investigation.Supplemental data for this
article is available online at at
10.1080/01635581.2021.1957133.},
cin = {C120},
ddc = {610},
cid = {I:(DE-He78)C120-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34369225},
doi = {10.1080/01635581.2021.1957133},
url = {https://inrepo02.dkfz.de/record/170152},
}